510(k) Report

510(k) · Cleared

Cleared

BD Veritor System for Rapid Detection of Flu A + B Labratory Kit

K160164510(k) SpecialCleared Feb 25, 201629-day reviewClass II21 CFR 866.3328

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Becton, Dickinson & CO · PSZ Devices Detecting Influenza A, B, And C Virus Antigens

Cleared on Feb 25, 2016 as substantially equivalent to K120049 (Becton, Dickinson and Company, 2012) and 6 other predicates after a 29-day review. Its family tree reaches back 12 generations to 1990.

Decided
Feb 25, 2016
Review
29 days
Class
Class II
Product code
PSZ
Recalls
None
Predicates
7

Its longest line of descent runs back 12 generations to K902609 (1990). 18 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 12 generations backK902609 Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic · 1990
  2. 8 generations between
  3. 3 generations backK133138 BD Veritor™ System Flu A+B AssayBecton, Dickinson & CO · 2013
  4. 2 generations backK151301 BD Veritor™ System Flu A+B AssayBecton, Dickinson and Company · 2015
  5. 1 generation backK152874 BD Veritor System for the Rapid Detection of Flu A + B Laboratory kitBecton, Dickinson and Co. · 2015
  6. This deviceK160164 BD Veritor System for Rapid Detection of Flu A + B Labratory KitBecton, Dickinson & CO · 2016
Show all 12 generations
  1. Root · 12 generations backK902609 Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic · 1990
  2. 11 generations backK981651 AB Flu OiaBiostar, Inc. · 1998
  3. 10 generations backK023556 Flu Oia a/B Test KitThermo Biostar, Inc. · 2003 · Recalled
  4. 9 generations backK031899 Quickvue Influenza a+B TestQuidel Corp. · 2003
  5. 8 generations backK053146 Quickvue Influenza a + B TestQuidel Corp. · 2005
  6. 7 generations backK092698 Quickvue Influenza a+B TestQuidel Corp. · 2009
  7. 6 generations backK112277 BD Veritor (TM) System for Rapid Detection of Flu a+BBecton, Dickinson and Company · 2011 · Recalled
  8. 5 generations backK132259 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013
  9. 4 generations backK132692 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013
  10. 3 generations backK133138 BD Veritor™ System Flu A+B AssayBecton, Dickinson & CO · 2013
  11. 2 generations backK151301 BD Veritor™ System Flu A+B AssayBecton, Dickinson and Company · 2015
  12. 1 generation backK152874 BD Veritor System for the Rapid Detection of Flu A + B Laboratory kitBecton, Dickinson and Co. · 2015
  13. This deviceK160164 BD Veritor System for Rapid Detection of Flu A + B Labratory KitBecton, Dickinson & CO · 2016
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−12K902609Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic1990—
−11K981651AB Flu OiaBiostar, Inc.1998—
−10K023556Flu Oia a/B Test KitThermo Biostar, Inc.20031
−9K031899Quickvue Influenza a+B TestQuidel Corp.2003—
−8K053146Quickvue Influenza a + B TestQuidel Corp.2005—
−7K092698Quickvue Influenza a+B TestQuidel Corp.2009—
−6K112277BD Veritor (TM) System for Rapid Detection of Flu a+BBecton, Dickinson and Company20111
−5K132259BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company2013—
−4K132692BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company2013—
−3K133138BD Veritor™ System Flu A+B AssayBecton, Dickinson & CO2013—
−2K151301BD Veritor™ System Flu A+B AssayBecton, Dickinson and Company2015—
−1K152874BD Veritor System for the Rapid Detection of Flu A + B Laboratory kitBecton, Dickinson and Co.2015—
0 (this device)K160164BD Veritor System for Rapid Detection of Flu A + B Labratory KitBecton, Dickinson & CO2016—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200010
201220
201320
FIG. 1 — Lineage of K160164, 1990–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PSZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PSZ device

  1. #1 K252283 Nano-Check Influenza A+B Testscore 14.9 · 15 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (7)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K120049BD Veritor System for the Rapid Detection of Flu a+B
Summary page 5
…GNX PREDICATE DEVICES : BD Veritor™ System for Rapid Detection of Flu A+B Laboratory kit (k120049, k121797, k132256, k132693, k133138, k151301, k152874) INTENDED USE : Kit for Labo…
Becton, Dickinson and Company2012—
*K121797BD Veritor (TM) System for Rapid Detection of Flu a+B
Summary page 5
…X PREDICATE DEVICES : BD Veritor™ System for Rapid Detection of Flu A+B Laboratory kit (k120049, k121797, k132256, k132693, k133138, k151301, k152874) INTENDED USE : Kit for Laboratory Us…
Becton, Dickinson and Company2012—
*K132256BD Veritor System for the Rapid Detection of Flu a+B
Summary page 5
…ATE DEVICES : BD Veritor™ System for Rapid Detection of Flu A+B Laboratory kit (k120049, k121797, k132256, k132693, k133138, k151301, k152874) INTENDED USE : Kit for Laboratory Use The BD…
Becton, Dickinson and Company2013—
*K132693BD Veritor™ System Flu A+B Assay
Summary page 5
…ES : BD Veritor™ System for Rapid Detection of Flu A+B Laboratory kit (k120049, k121797, k132256, k132693, k133138, k151301, k152874) INTENDED USE : Kit for Laboratory Use The BD Veritor™…
Becton, Dickinson and Company2013—
*K133138BD Veritor™ System Flu A+B Assay
Summary page 5
…apid Detection of Flu A+B Laboratory kit (k120049, k121797, k132256, k132693, k133138, k151301, k152874) INTENDED USE : Kit for Laboratory Use The BD Veritor™ System for Rapid Detection of Flu A+B is a rapid chroma…
Becton, Dickinson & CO2013—
*K151301BD Veritor™ System Flu A+B Assay
Summary page 5
…ction of Flu A+B Laboratory kit (k120049, k121797, k132256, k132693, k133138, k151301, k152874) INTENDED USE : Kit for Laboratory Use The BD Veritor™ System for Rapid Detection of Flu A+B is a rapid chromatographic…
Becton, Dickinson and Company2015—
*K152874BD Veritor System for the Rapid Detection of Flu A + B Laboratory kit
Summary page 5
…Flu A+B Laboratory kit (k120049, k121797, k132256, k132693, k133138, k151301, k152874) INTENDED USE : Kit for Laboratory Use The BD Veritor™ System for Rapid Detection of Flu A+B is a rapid chromatographic immunoas…
Becton, Dickinson and Co.2015—

Also cleared against K120049: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 7 companies; a new generation was cleared every 1.8 years on median.
  • 2 of the 18 ancestors have a recall of any class.
  • 5 other devices also cite its predicate K120049.

How does its category compare?

All PSZ devices

PSZ Devices Detecting Influenza A, B, And C Virus Antigens: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · PSZ

2in 2025

2007: 22008: 12009: 72010: 52011: 32012: 22013: 82014: 12015: 42016: 32017: 32018: 52020: 22023: 22025: 22026 (partial year): 2
2007high 8 (2013) · low 0 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PSZ

28in 2018

2009: 20 days median2010: 29 days median2011: 80 days median2013: 28 days median2015: 27 days median2016: 29 days median2017: 200 days median2018: 28 days median
2007high 200 (2017) · low 20 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PSZ

1in 2022

2020: 12022: 1
2007high 1 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PSZ

60in 2025

2018: 12019: 12020: 52021: 422022: 102023: 122024: 162025: 60
2007high 60 (2025) · low 0 (2007)2025

MAUDE reports naming product code PSZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
200972000
201052900
201138000
20122—00
201382800
20141—00
201542700
201632900
2017320000
201852801
20190—01
20202—15
20210—042
20220—110
20232—012
20240—016
20252—060
20262—0—

What is it indicated for?

The BD Veritor™ System for Rapid Detection of Flu A+B is a rapid chromatographic immunoassay for the direct and qualitative detection of influenza A and B viral nucleoprotein antigens from nasopharyngeal wash, aspirate, and swab in transport media samples from symptomatic patients. The BD Veritor System for Rapid Detection of Flu A+B is a differentiated test, such that influenza A viral antigens can be distinguished from influenza B viral antigens from a…

Read the full statement (411 words)

The BD Veritor™ System for Rapid Detection of Flu A+B is a rapid chromatographic immunoassay for the direct and qualitative detection of influenza A and B viral nucleoprotein antigens from nasopharyngeal wash, aspirate, and swab in transport media samples from symptomatic patients. The BD Veritor System for Rapid Detection of Flu A+B is a differentiated test, such that influenza A viral antigens can be distinguished from influenza B viral antigens from a single processed sample using a single device. The test is to be used as an aid in the diagnosis of influenza A and B viral infections. A negative test is presumptive and it is recommended that these results be confirmed by viral culture or an FDA-cleared influenza A and B molecular assay. Outside the U.S. a negative test is presumptive and it is recommended that these results be confirmed by viral culture or a molecular assay cleared for diagnostic use in the country of use. FDA has not cleared this device outside the U.S. Negative test results do not preclude influenza viral infection and should not be used as the sole basis for treatment or other patient management decisions. The test is not intended to detect influenza C antigens.

Performance characteristics for influenza A and B nasopharyngeal (NP) washes/aspirates were established during January through March of 2011 when influenza viruses A/2009 H1N1, A/H3N2, B/Victoria lineage, and B/Yamagata lineage were the predominant influenza viruses in circulation according to the Morbidity and Mortality Weekly Report from the CDC entitled “Update: Influenza Activity—United States, 2010-2011 Season, and Composition of the 2011-2012 Influenza Vaccine.” Performance characteristics may vary against other emerging influenza viruses.

Performance characteristics for influenza A and B NP swabs in transport media were established during January through April of 2012 when influenza viruses A/2009 H1N1, A/H3N2, B/Victoria lineage, and B/Yamagata lineage were the predominant influenza viruses in circulation according to the Morbidity and Mortality Weekly Report from the CDC entitled “Update: Influenza Activity—United States, 2011-2012 Season, and Composition of the 2012-2013 Influenza Vaccine.” Performance characteristics may vary against other emerging influenza viruses.

If infection with a novel influenza virus is suspected based on current clinical and epidemiological screening criteria recommended by public health authorities, specimens should be collected with appropriate infection control precautions for novel virulent influenza viruses and sent to the state or local health department for testing. Virus culture should not be attempted in these cases unless a BSL 3+ facility is available to receive and culture specimens.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K160164: BD Veritor System for Rapid Detection of Flu A + B Labratory Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K160164

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026